Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Kritika Sarmah

FOUND: Are wall street analysts bullish on cencora stock | Mind Blowing Facts

With a market cap of approximately $50.8 billion, Cencora, Inc. (COR) is one of the world’s largest pharmaceutical services and drug distribution companies, providing healthcare products, specialty medicines, and supply chain solutions to pharmacies, hospitals, physician practices, and healthcare providers globally. Headquartered in Conshohocken, Pennsylvania, the company plays a critical role in the pharmaceutical supply chain by helping deliver medications efficiently and securely across the healthcare system.

The pharma distributor has lagged behind the broader market over the past year. COR stock has dipped 8.4% over the past 52 weeks, compared to the S&P 500 Index’s ($SPX) 26.5% gains. In 2026, the stock is down 24.3%, trailing the index’s 8.8% rise. 

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.